KDM5B, also known as JARID1B, was required to maintain tumorigeneic activity in melanoma cells [29], and the knockdown of KDM5B may trigger apoptosis and reduces proliferation in bladder and lung cancers [25]. Here, KDM5B is linked to melanoma.